Transformative Imaging for Quantitative Biology (TIQBio) Partnership

EPSRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

March 29, 2027
Response Due
Active
Status

Opportunity Overview

The Transformative Imaging for Quantitative Biology (TIQBio) partnership aims to develop disruptive technology for the benefit of UK Plc and for solving problems in industry and academia. The mainstay of current imaging methods to look at pre-clinical biological samples is fluorescence microscopy. This technique relies on the use of tags, which emit light when illuminated by the microscope, allowing the location of the structures or molecules to which they are attached to be determined. Insertion or attachment of a tag is an invasive process for any living system and can alter its behaviour and the way it functions. Furthermore, all living systems, tissue and cells are inherently 3-dimensional. Therefore to image in 3D one has to point-by-point collect fluorescence signal and reconstruct an image. This is a very slow and damaging process especially for 3-D live samples that represent real-life conditions. For discovering new drugs or for studying mechanisms in diseases or healing it is obvious that one should use conditions that are as near to real life as possible, before human testing. This is why most biomedical researchers and industrial sectors that operate in the area of diseases, drugs or therapeutics want to use life-like samples. At the moment however, the tools to image them in 3D and in an unperturbed, non-damaging manner simply do not exist. Furthermore, it is desirable to work at the highest resolution so we can see the smallest things that exist at the nanoscale in such biological systems and obtain holistic information about the chemical composition and structural order. This information will reveal unprecedented insight and hence help understand diseases or why a particular drug candidate does or does not work allowing better ones to be made. TIQBio will address these challenges so that unperturbed, live imaging can be carried out at an unprecedented resolution level in full 3D, with holistic information from multiple readouts carried out rapidly on...

This is one of 26 active United Kingdom Medical Equipment opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyEPSRC
CountryUnited Kingdom
CategoryMedical Equipment
PublishedMarch 30, 2022
Procurement stageActive solicitation
Response dueMarch 29, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Integrated Pathology Hub and Laboratory Equipment Managed Service Partner
SEL Community Diagnostic Centre (CDC): Main Contractor
Community Diagnostic Centre Main Contractor
Diagnostic and Antibiotic Stewardship for Urinary Tract Infections Using Fit-for-Purpose Diagnostic Tools
MAST-U Diagnostic Equipment
AMICI: Amorphous Microstructure Imaging at Composite Interfaces in Metal-Organic Frameworks
ClearSERS - A Novel Imaging Concept
Delivery of rapid diagnostic tests for sustainable control of parasitic diseases in sheep and cattle

See every United Kingdom Medical Equipment opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Medical Equipment intelligence report in your inbox

A personalized report on United Kingdom Medical Equipment opportunities, emailed in 5-10 minutes. One per month, no account needed.